Werner Lubitz, MSc, PhD, Professor, VP R&D, Founder, Biotech Innovation Research Development & Consulting | BIRD-C, Vienna, Austria
Scopus h-index — 52
Web of Science h-index — 29
Full Professor of Microbiology and Biotechnology at the University of Vienna, Austria, at the Department of Medicinal Chemistry, and the Center of Molecular Biology, Vienna Biocenter.
Werner Lubitz holds an MSc and a PhD in Microbiology from the Technical University of Munich, Germany. He obtained his postdoctoral training in Cell- and Tumor-Biology at the Institute of Cell Biology, University of Munich, Germany, at the Centre Hopitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, at the Wallenberg Laboratories, University of Uppsala, Sweden, at the Biocenter, University of Basel, Switzerland, and at the Max Plank Institute of Neurobiology, Martinsried, Germany, and in Genetic Engineering and Microbiology at the Institute of Microbiology, University of Victoria, Canada.
He is the inventor of the Bacterial Ghost Platform Technology (BGPT) and holds an extensive patent portfolio. Werner is the founder and cofounder of three Biotech Companies including BIRD-C holding the position of CEO/CSO of the latter company exploring different application areas of the BGPT.
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.